May Silymarin be selectively considered for nonalcoholic fatty liver disease without elevated transaminases? Comment re. “Impact of Silymarin in individuals with nonalcoholic fatty liver disease: a systematic review and meta-analysis”

Saved in:
Bibliographic Details
Published inNutrition (Burbank, Los Angeles County, Calif.) Vol. 102; p. 111648
Main Authors Liu, Lu, Li, Yiling, Qi, Xingshun
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.10.2022
Elsevier Limited
Subjects
Diabetes
Fatty liver
Liver
Liver diseases
Meta-analysis
Metabolic syndrome
Silymarin
Systematic review
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Commentary-4
ObjectType-Correspondence-1
content type line 23
ObjectType-Undefined-5
ObjectType-Feature-2
ObjectType-Article-3
ISSN:0899-9007
1873-1244
DOI:10.1016/j.nut.2022.111648